Preferences Of The General Public For Reimbursement Criteria For Expensive Drugs: A Multi Criteria Decision Analysis For Rituximab And Bevacizumab
2017
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI